drugset / Trial / NCT04650126
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Atrosimab (ATM001) in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a double-blind, parallel group and placebo-controlled clinical study to assess safety tolerability, pharmacokinetics and pharmacodynamics of Atrosimab in healthy volunteers
Timeline
- Start
- 2021-07-12
- Primary completion
- 2022-03-24
- Completion
- 2022-03-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATM001 | Unknown | — | Intravenous |
Indications
No indication recorded.